Rhabdomyolysis, Methamphetamine, Amphetamine and MDMA Use: Associated Factors and Risks

John R Richards1, Colin G Wang1, Roderick W Fontenette1

  • 1Department of Emergency Medicine, Davis Medical Center, University of California, Sacramento, CA, USA.

Abstract

Insights

Rhabdomyolysis, a condition linked to methamphetamine and amphetamine use, occurred in 20% of MA-positive patients. Key risk factors include male gender and elevated kidney and cardiac markers.

Area of Science:

  • Toxicology
  • Emergency Medicine
  • Nephrology

Background:

  • Rhabdomyolysis is a known complication of stimulant use, including methamphetamine (MA).
  • Understanding the frequency and risk factors of MA-associated rhabdomyolysis is crucial for clinical management.

Purpose of the Study:

  • To determine the frequency, severity, and risk factors of rhabdomyolysis in patients with MA-positive toxicology screens.
  • To identify patient characteristics and laboratory findings associated with MA-induced rhabdomyolysis.

Main Methods:

  • Retrospective review of 7,319 patients with MA-positive toxicology screens over 6 years.
  • Included 957 patients screened for rhabdomyolysis based on creatine kinase (CK) levels.
  • Recorded demographics, vital signs, diagnoses, laboratory results, and disposition.

Main Results:

  • 20% (190/957) of MA-positive patients developed rhabdomyolysis, with a median CK of 2,610 U/L.
  • Patients with rhabdomyolysis showed significant differences in renal function, gender, and troponin I levels compared to those without.
  • Concomitant cocaine use and male gender were associated with a higher incidence of rhabdomyolysis.

Conclusions:

  • The incidence of rhabdomyolysis in MA-positive individuals is 20%.
  • Elevated troponin I, blood urea nitrogen, creatinine, and male gender are significant risk factors for rhabdomyolysis in this population.
  • Clinicians should suspect rhabdomyolysis in MA-positive patients, particularly with abnormal renal/cardiac labs, even without apparent injury.

Related Concept Videos

Drug Abuse and Addiction: Pharmacological Phenomena01:15

Drug Abuse and Addiction: Pharmacological Phenomena

Drug dependence, abuse, and addiction are complex phenomena that can precipitate various abnormal states. Physical dependence refers to a state of pharmacological adaptation to a drug. This adaptation often results in tolerance—a reduced response to the drug after repeated administrations. When the drug use is abruptly stopped, withdrawal symptoms occur due to the body's need to readjust from the pharmacologically induced imbalance. However, tolerance and withdrawal symptoms do not...
987
Stimulants01:29

Stimulants

Stimulants are substances that enhance neural activity and elevate dopamine levels in the brain, leading to their highly addictive nature. These drugs include cocaine, amphetamines, MDMA, caffeine, and nicotine, each with distinct mechanisms of action and varied health implications.
Cocaine can be administered via snorting, injection, or smoking. It primarily functions by blocking the reuptake of dopamine, resulting in a euphoric high characterized by an intense sensation of happiness and...
728
CNS Stimulants: Cocaine, Amphetamines and Cannabinoids01:24

CNS Stimulants: Cocaine, Amphetamines and Cannabinoids

CNS stimulants, such as cocaine, amphetamines, and cannabinoids, have varying structures and mechanisms of action that lead to different therapeutic effects and side effects. Cocaine, with its molecular formula C17H21NO4, is a tropane alkaloid and a tertiary amino compound. It has two chemical forms: the hydrochloride salt and the "freebase." The former is in powder form, while the latter involves removing the hydrochloride salt to create a form that can be smoked. Cocaine exerts its...
639
Drugs Acting on Autonomic Ganglia: Stimulants01:23

Drugs Acting on Autonomic Ganglia: Stimulants


Ganglionic stimulants activate NM nicotinic receptors in autonomic ganglia, falling into two categories: nicotine mimetics [e.g., lobeline, dimethylpiperazine, tetramethylammonium] and muscarinic receptor agonists [e.g., muscarine, methacholine]. The first category's action is rapid and blocked by nicotinic receptor antagonists, while the second category's action is delayed and blocked by atropine-like agents. Nicotine, an alkaloid, affects the heart rate by stimulating...
1.9K
Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
401
Drugs Affecting Neurotransmitter Synthesis01:29

Drugs Affecting Neurotransmitter Synthesis

Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.0K